Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1996;87:489-493
© 1996 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oshiro, B.
Right arrow Articles by Branch, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshiro, B.
Right arrow Articles by Branch, D.

Articles

Antiphospholipid antibodies and fetal death

BT Oshiro, RM Silver, Scott JR, H Yu, and DW Branch

OBJECTIVE: To determine the type of recurrent pregnancy loss associated with antiphospholipid antibodies. METHODS: This was a retrospective analysis of women who had two or more pregnancy losses and who were tested for antiphospholipid antibodies. The specific type of pregnancy losses were determined in patients with and without antiphospholipid antibodies. RESULTS: In our highly selected referral population, 76 of 366 women (21%) tested positive for lupus anticoagulant or anticardiolipin antibodies of 20 or more immunoglobulin-G phospholipid antibody units. Pregnancy loss occurred in 280 of 333 (84%) prior pregnancies in women with and 1240 of 1479 (84%) without antiphospholipid antibodies. However, 50% of pregnancy losses in women with antiphospholipid antibodies were fetal deaths, compared with less than 15% in women who were antiphospholipid antibody-negative. More than 80% of women with antiphospholipid antibodies had at least one fetal death, compared with less than 25% of women without (P < .001). The specificity of fetal death for the presence of antiphospholipid antibodies in patients with recurrent pregnancy loss was 76%. In contrast, two or more early first-trimester losses without fetal death had a specificity of only 6% for antiphospholipid antibodies. CONCLUSION: Fetal death is more characteristic of the type of loss experienced by patients with recurrent pregnancy loss than early first-trimester pregnancy loss in women with antiphospholipid antibodies.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
S. M. Nelson and I. A. Greer
The potential role of heparin in assisted conception
Hum. Reprod. Update, November 1, 2008; 14(6): 623 - 645.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
R. Cervera and J. Balasch
Bidirectional effects on autoimmunity and reproduction
Hum. Reprod. Update, May 22, 2008; (2008) dmn013v1.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
U. M. Reddy
Prediction and Prevention of Recurrent Stillbirth
Obstet. Gynecol., November 1, 2007; 110(5): 1151 - 1164.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Sabatini, M. Torricelli, V. Scaccia, D. Fineschi, M. Pescaglini, L. Gasparri, P. Florio, and F. Petraglia
Increased Plasma Concentrations of Antiprothrombin Antibodies in Women with Recurrent Spontaneous Abortions
Clin. Chem., February 1, 2007; 53(2): 228 - 232.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
R. M. Silver
Fetal Death
Obstet. Gynecol., January 1, 2007; 109(1): 153 - 167.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
W. Lim, M. A. Crowther, and J. W. Eikelboom
Management of Antiphospholipid Antibody Syndrome: A Systematic Review
JAMA, March 1, 2006; 295(9): 1050 - 1057.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
R. L. Bick and D. Hoppensteadt
Recurrent Miscarriage Syndrome and Infertility Due to Blood Coagulation Protein/Platelet Defects: A Review and Update
Clinical and Applied Thrombosis/Hemostasis, January 1, 2005; 11(1): 1 - 13.
[Abstract] [PDF]


Home page
LupusHome page
M Blank and Y Shoenfeld
Antiphosphatidylserine antibodies and reproductive failure
Lupus, September 1, 2004; 13(9): 661 - 665.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
A. E. Frias Jr, R. A. Luikenaar, A. E. Sullivan, R. M. Lee, T F. Porter, D W. Branch, and R. M. Silver
Poor Obstetric Outcome in Subsequent Pregnancies in Women With Prior Fetal Death
Obstet. Gynecol., September 1, 2004; 104(3): 521 - 526.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
V. Hurtado, R. Montes, J.-C. Gris, M. L. Bertolaccini, A. Alonso, M. A. Martinez-Gonzalez, M. A. Khamashta, K. Fukudome, D. A. Lane, and J. Hermida
Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death
Blood, September 1, 2004; 104(5): 1369 - 1374.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
J. G. Hanly
Antiphospholipid syndrome: an overview
Can. Med. Assoc. J., June 24, 2003; 168(13): 1675 - 1682.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. S. Levine, D. W. Branch, and J. Rauch
The Antiphospholipid Syndrome
N. Engl. J. Med., March 7, 2002; 346(10): 752 - 763.
[Full Text] [PDF]


Home page
NEJMHome page
I. Martinelli, E. Taioli, I. Cetin, A. Marinoni, S. Gerosa, M. V. Villa, M. Bozzo, and P. M. Mannucci
Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss
N. Engl. J. Med., October 5, 2000; 343(14): 1015 - 1018.
[Abstract] [Full Text] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
R. L. Bick
Recurrent Miscarriage Syndrome due to Blood Coagulation Protein/Platelet Defects: Prevalence, Treatment and Outcome Results
Clinical and Applied Thrombosis/Hemostasis, July 1, 2000; 6(3): 115 - 125.
[Abstract] [PDF]


Home page
LupusHome page
J Carbone, M Orera, M Rodriguez-Mahou, C Rodriguez-Perez, S Sanchez-Ramon, E Seoane, J J Rodriguez, J M Zabay, and E Fernandez-Cruz
Immunological abnormalities in primary APS evolving into SLE: 6 years follow-up in women with repeated pregnancy loss
Lupus, May 1, 1999; 8(4): 274 - 278.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
A. LYNCH, T. BYERS, W. EMLEN, D. RYNES, S. M. SHETTERLY, and R. F. HAMMAN
Association of Antibodies to Beta2-Glycoprotein 1 With Pregnancy Loss and Pregnancy-Induced Hypertension: A Prospective Study in Low-Risk Pregnancy
Obstet. Gynecol., February 1, 1999; 93(2): 193 - 198.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. A. Hill
Immunotherapy for Recurrent Pregnancy Loss: "Standard of Care of Buyer Beware"
Reproductive Sciences, November 1, 1997; 4(6): 267 - 273.
[PDF]


Home page
JWatch Women's HealthHome page
Antiphospholipid Antibodies and Type of Pregnancy Loss
Journal Watch Women's Health, May 1, 1996; 1996(501): 21 - 21.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American College of Obstetricians and Gynecologists.